By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
Hi Jack:
re IVIG for DM.
The approval of octagam 10% was partly related to a recent study: Aggarwal R et al Medicine 2021 - methods; EULAR 2021 podium OP0007 - results (published in Annals Rheum Dis).